BioNTech SE (BNTX)
112.82
-3.75
(-3.22%)
USD |
NASDAQ |
Aug 24, 16:00
113.17
+0.35
(+0.31%)
After-Hours: 20:00
BioNTech EPS Diluted (Quarterly) : -3.799 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.799 |
| March 31, 2026 | -2.461 |
| December 31, 2025 | -1.448 |
| September 30, 2025 | -0.1395 |
| June 30, 2025 | -1.823 |
| March 31, 2025 | -1.821 |
| December 31, 2024 | 1.154 |
| September 30, 2024 | 0.8898 |
| June 30, 2024 | -3.658 |
| March 31, 2024 | -1.422 |
| December 31, 2023 | 2.036 |
| September 30, 2023 | 0.7289 |
| June 30, 2023 | -0.8642 |
| Date | Value |
|---|---|
| March 31, 2023 | 2.200 |
| December 31, 2022 | 9.446 |
| September 30, 2022 | 7.027 |
| June 30, 2022 | 6.864 |
| March 31, 2022 | 15.97 |
| December 31, 2021 | 14.92 |
| September 30, 2021 | 14.56 |
| June 30, 2021 | 12.98 |
| March 31, 2021 | 5.288 |
| December 31, 2020 | 1.811 |
| September 30, 2020 | -1.028 |
| June 30, 2020 | -0.4185 |
| March 31, 2020 | -0.2593 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -1.965 |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0437 |
| NuCana Plc | -1.007 |
| MediGene AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -954.35M |
| Revenue (Quarterly) | 122.78M |
| Total Expenses (Quarterly) | 1.077B |
| Enterprise Value | 12.75B |
| Gross Profit Margin (Quarterly) | -169.3% |
| Profit Margin (Quarterly) | -777.3% |
| Earnings Yield | -6.96% |
| Normalized Earnings Yield | -3.797 |